정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 345 | Active, not recruiting | Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) | Coronavirus Disease 2019 | Drug: Placebos Drug: Leronlimab (700mg) |
Phase 2 | CytoDyn, Inc. | INDUSTRY | 394 | All | 18 Years | Advanced Cardiovascular, LLC, Alexander City, Alabama, United States St. Jude Medical Center, Fullerton, California, United States UCLA, Los Angeles, California, United States James A. Haley Veterans' Hospital, Tampa, Florida, United States Center for Advanced Research & Education (CARE), Gainesville, Georgia, United States Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States St. Barnabas, Livingston, New Jersey, United States Atlantic Health System Hospital, Morristown, New Jersey, United States Holy Name Medical Center, Teaneck, New Jersey, United States Montefiore Medical Center, Bronx, New York, United States New York Community Hospital of Brooklyn, Brooklyn, New York, United States Novant Health, Winston-Salem, North Carolina, United States Ohio Health, Columbus, Ohio, United States Good Samaritan Hospital Corvallis, Corvallis, Oregon, United States Oregon Health and Sciences University, Portland, Oregon, United States Baylor Scott & White Research Institute, Dallas, Texas, United States Baylor College of Medicine, Houston, Texas, United States University of Texas, Houston, Texas, United States |
| 344 | Recruiting | Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). | COVID-19 | Drug: Maraviroc 300 mg Other: Standard care therapy |
Phase 2 | Hospital Universitario Infanta Leonor, Hospital Clinic of Barcelona, ViiV Healthcare | OTHER | 200 | All | 18 Years | Hospital Clinic, Barcelona, Spain Hospital Universitario Infanta Leonor, Madrid, Spain |
| 343 | Recruiting | Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection. | SARS-CoV-2 Infection | Drug: RP7214 + Standard of care (SOC) Drug: Placebo + Standard of care (SOC) |
Phase 2 | Rhizen Pharmaceuticals SA, Incozen Therapeutics Pvt Ltd | INDUSTRY | 204 | All | 18 Years | Panimalar medical college hospital and research institute, Chennai, India Great Eastern medical school and hospital, Srikakulam, India |
| 342 | Terminated | Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting | COVID-19 | Drug: RDV Drug: Placebo to Match RDV |
Phase 3 | Gilead Sciences | INDUSTRY | 585 | All | 12 Years | Arizona Liver Health, Chandler, Arizona, United States Arizona Clinical Trials, Tucson, Arizona, United States St Joseph Hospital Eureka, Eureka, California, United States St. Joseph Heritage Healthcare, Fullerton, California, United States Elevated Health, Huntington Beach, California, United States Ruane Clinical Research Group, Los Angeles, California, United States LA Universal Center, INC., Los Angeles, California, United States Mills Clinical Research, Los Angeles, California, United States Kaiser Permanente Northern California, Oakland, California, United States FOMAT Medical Research, Oxnard, California, United States UC Davis Health, Sacramento, California, United States Kaiser Permanente Northern California, 6600 Bruceville Road, Sacramento, California, United States Kaiser Permanente Northern California, 2025 Morse Ave, Sacramento, California, United States Kaiser Permanente Northern California, 1200 El Camino Real, San Francisco, California, United States Kaiser Permanente Northern California, 2425 Geary Blvd, San Francisco, California, United States UCSF Medical Center, San Francisco, California, United States Kaiser Permanente Northern California, 250 Hospital Parkway, Suite 850, San Jose, California, United States Kaiser Permanente Northern California, 2500 Merced St, San Leandro, California, United States St. Joseph Heritage Healthcare, Santa Rosa, California, United States Premiere Medical Center of Burbank, Inc, Toluca Lake, California, United States Kaiser Permanente Northern California, 975 Sereno Drive, Vallejo, California, United States New Hope Research Development DBA HCD, Whittier, California, United States Centura Health Porter Place, Denver, Colorado, United States Nuvance Health, Danbury, Connecticut, United States RecioMed Clinical Research Network, Boynton Beach, Florida, United States Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States Invesclinic, Fort Lauderdale, Florida, United States Lawnwood Regional Medical Center, Fort Pierce, Florida, United States Evolution Clinical Trials, Hialeah Gardens, Florida, United States Encore Medical Research, Hollywood, Florida, United States Advanced Pulmonary Research Institute, Loxahatchee Groves, Florida, United States L&C Professional Medical Research Institute, Miami, Florida, United States Laguna Clinical Research Associates, Miami, Florida, United States CTMD Research, Inc, Palm Springs, Florida, United States IMIC Inc, Palmetto Bay, Florida, United States Luminous Clinical Research - South Florida Urgent Care, Pembroke Pines, Florida, United States St. Josephs Comprehensive Research Institute, Tampa, Florida, United States AIDS Research and Treatment Center of the Treasure Coast, Vero Beach, Florida, United States Triple O Research Institute PA, West Palm Beach, Florida, United States Agile Clinical Research Trials, Atlanta, Georgia, United States Mercer University School of Medicine, Macon, Georgia, United States Infectious Disease Associates of Kansas City, P.C.Infectious Disease Associates of Kansas City, P.C., Burr Ridge, Illinois, United States Metro Infectious Disease Consultants, Burr Ridge, Illinois, United States NorthStar Medical Center, Chicago, Illinois, United States NorthShore University Healthsystem, Evanston, Illinois, United States Tulane University, New Orleans, Louisiana, United States Holy Cross Hospital, Inc., Baltimore, Maryland, United States University of Maryland Baltimore, Baltimore, Maryland, United States Tufts Medical Center, Boston, Massachusetts, United States South Shore Hospital, South Weymouth, Massachusetts, United States VA Boston Healthcare System, West Roxbury, Massachusetts, United States Be Well Medical Center, Berkley, Michigan, United States Onyx Research Institute, Flint, Michigan, United States Memorial Hospital of Gulfport, Gulfport, Mississippi, United States Metro Infectious Disease Consultants, Kansas City, Missouri, United States Quality Clinical Research Inc., Omaha, Nebraska, United States AB Clinical Trials, Las Vegas, Nevada, United States AXCES Research Group, Santa Fe, New Mexico, United States New York Presbyterian Hospital, Flushing, New York, United States Northwell Health, New Hyde Park, New York, United States Atrium Health Carolinas Medical Center, Charlotte, North Carolina, United States East Carolina University, Greenville, North Carolina, United States Rosedale Infectious Diseases, Huntersville, North Carolina, United States Christ Hospital, Cincinnati, Ohio, United States Cherokee Nation WW Hastings Hospital, Tahlequah, Oklahoma, United States Providence St. Vincent Medical Center, Portland, Oregon, United States Temple University, Philadelphia, Pennsylvania, United States Avera Research Institute, Sioux Falls, South Dakota, United States University of Tennessee Health Science Center, Knoxville, Tennessee, United States Central Texas Clinical Research, Austin, Texas, United States UT Physicians, Bellaire, Texas, United States Baylor University Medical Center, 700 Scott and White Dr., College Station, Texas, United States Baylor University Medical Center, Dallas, Texas, United States UT Southwestern Medical Center, Dallas, Texas, United States Care United Research, LLC, Forney, Texas, United States VIP Trials, Harlingen, Texas, United States University of Texas, Houston, Texas, United States The Crofoot Research Center, Inc, Houston, Texas, United States Baylor University Medical Center, 1901 North McArthur Blvd, Irving, Texas, United States Laguna Clinical Research Associates, Laredo, Texas, United States Diagnostic Clinic of Longview - Center for Clinical Research, Longview, Texas, United States STAAMP Research, San Antonio, Texas, United States Sugar Lakes Family Practice, Sugar Land, Texas, United States Baylor University Medical Center, 2201 MacArthur Dr., Suite 100, Waco, Texas, United States ClinPoint Trials, Waxahachie, Texas, United States Intermountain Healthcare, Murray, Utah, United States Virginia Commonwealth University, Richmond, Virginia, United States Providence Regional Medical Center Everett, Everett, Washington, United States Sound Medical Research, Port Orchard, Washington, United States Fred Hutchinson Cancer Research Center, Seattle, Washington, United States Providence Medical Research Center, Spokane, Washington, United States Wisconsin Corporation for Biomedical Research, Milwaukee, Wisconsin, United States Aalborg University Hospital, Aalborg, Denmark Aarhus University Hospital, Aarhus N, Denmark Rigshospitalet, Copenhagen, Denmark Hvidovre Hospital, Hvidovre, Denmark Odense University Hospital, Odense, Denmark Hospital Senhora da Oliveira, Guimaraes, Portugal Hospital Universitari Germans Trias i Pujol, Badalona, Spain Hospital Clinic, Barcelona, Spain Hospital Universitario Infanta Leonor, Madrid, Spain Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom University College Hospital, London, United Kingdom St Mary's Hospital, London, United Kingdom Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom |
| 341 | Recruiting | Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) | COVID-19 | Drug: Remdesivir Drug: RDV Placebo Drug: Standard of Care |
Phase 3 | Gilead Sciences | INDUSTRY | 1116 | All | 12 Years | St. Vincent's Health System, Birmingham, Alabama, United States UAB Hospital, Birmingham, Alabama, United States Pulmonary Associates of Mobile, P.C., Mobile, Alabama, United States St. Joseph Hospital Eureka, Eureka, California, United States Hoag Memorial Hospital Presbyterian, 16200 Sand Canyon Ave, Irvine, California, United States Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States Sutter Medical Center Sacramento, Sacramento, California, United States San Francisco VA Medical Center, San Francisco, California, United States Stanford Hospital and Clinics, Stanford, California, United States Torrance Memorial Medical Center, Torrance, California, United States MedStar Health Research Institute, Washington, District of Columbia, United States George Washington Medical Faculty Associates, Washington, District of Columbia, United States North Florida/ South Georgia Veterans Health System, Gainesville, Florida, United States Mayo Clinic Florida, Jacksonville, Florida, United States Genesis Clinical Research, Tampa, Florida, United States Cleveland Clinic Florida, Weston, Florida, United States Northwestern University Comprehensive Transplant Center, Chicago, Illinois, United States University of Chicago, Chicago, Illinois, United States Great Lakes Clinical Trials, Chicago, Illinois, United States Northwestern Medicine Central DuPage Hospital, Winfield, Illinois, United States Baptist Health Lexington, Lexington, Kentucky, United States Rapides Regional Medical Center, Alexandria, Louisiana, United States Tulane Medical Center, 2000 Canal St., New Orleans, Louisiana, United States Tulane Medical Center, New Orleans, Louisiana, United States Maine Medical Center, Portland, Maine, United States Wake Forest University Health Sciences, Bethesda, Maryland, United States Holy Cross Hospital, 19801 Observation Dr, Germantown, Maryland, United States Holy Cross Hospital, Silver Spring, Maryland, United States Massachusetts General Hospital, Boston, Massachusetts, United States Newton-Wellesley Hospital, Newton, Massachusetts, United States St. Clair Nephrology Research, Grosse Pointe Woods, Michigan, United States G.V. (Sonny) Montgomery VAMC, Jackson, Michigan, United States Mayo Clinic Hospital, Rochester, Minnesota, United States University Medical Center of Southern Nevada, Las Vegas, Nevada, United States Renown Regional Medical Center, Reno, Nevada, United States Saint Michael's Medical Center, Newark, New Jersey, United States University of New Mexico Hospital, Albuquerque, New Mexico, United States Lincoln Medical Center, Bronx, New York, United States Jacobi Medical Center, Bronx, New York, United States Montefiore Medical Center, Bronx, New York, United States New York - Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States Stony Brook University Hospital, Stony Brook, New York, United States PMG Infectious Disease Consultants (administrative), Portland, Oregon, United States Oregon Health and Science University, Portland, Oregon, United States Temple University Hospital, Philadelphia, Pennsylvania, United States Medical University of South Carolina, Charleston, South Carolina, United States UT Southwestern Medical Center - ID Clinical Research Unit, Dallas, Texas, United States Houston Methodist Hospital, Houston, Texas, United States Memorial Hermann Hospital at TMC, Houston, Texas, United States University Hospital, San Antonio, Texas, United States VCU Health Medical Center, Richmond, Virginia, United States Providence Regional Medical Center Everett, Everett, Washington, United States Swedish Medical Center, Seattle, Washington, United States MultiCare Health System - Pulmonary and Critical Care Center, Spokane, Washington, United States Providence Health Care, Spokane, Washington, United States Providence Health Care, 5633 N Lidgerwood, Spokane, Washington, United States MultiCare Good Samaritan Hospital, Tacoma, Washington, United States Hospital Garcia de Orta, Almada, Portugal Centro Hospitalar Cova da Beira EPE, Covilha, Portugal Hospital Nelio Mendonca,, Funchal, Portugal Hospital Senhora da Oliveira, Guimaraes, Portugal Hospital da Luz, Lisboa, Portugal Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal Centro Hospitalar do Porto - Hospital de Santo Antonio, Odivelas, Portugal Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal Hospital Universitario Germans Trias I Pujol, Badalona, Spain Hospital Universitario de Cruces, Barakaldo, Spain Hospital del Mar, Barcelona, Spain Hospital Universitari de Bellvitge, Barcelona, Spain Hospital Clinic de Barcelona, Barcelona, Spain Hospital General Universitario de Elche, Elche, Spain Hospital General Universitario Gregorio Maranon, Madrid, Spain Hospital Universitario 12 de Octubre, Madrid, Spain Hospital General Universitario Reina Sofia, Murcia, Spain Complejo Asistencial Universitario de Salamanca - H. Clinico, Salamanca, Spain Hospital General Universitario de Valencia, Valencia, Spain Hospital Universitari i Politecnic La Fe, Valencia, Spain Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom Guy's & St Thomas Hospital, London, United Kingdom Kings College Hospital, London, United Kingdom Imperial College Healthcare NHS Trust, London, United Kingdom |
| 340 | Not yet recruiting | Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression | COVID-19 | Drug: Tocilizumab Drug: Methylprednisolone |
Phase 3 | University of Malaya | OTHER | 310 | All | 18 Years | University Malaya Medical Centre, Kuala Lumpur, Malaysia |
| 339 | Recruiting | Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient | SARS-CoV-2 Infection | Drug: Drug COVID19-0001-USR Drug: normal saline |
Phase 2 | United Medical Specialties | OTHER | 60 | All | 18 Years | Cimedical, Barranquilla, Atlantico, Colombia |
